Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule InhibitorGang Zhao, Philip R. Kym, Yau Yi Lau et al.|Journal of Medicinal Chemistry|2008Cited by 140
Liver-specific Knockdown of JNK1 Up-regulates Proliferator-activated Receptor γ Coactivator 1β and Increases Plasma Triglyceride despite Reduced Glucose and Insulin Levels in Diet-induced Obese MiceRuojing Yang, Terry Surowy, Denise M. Wilcox et al.|Journal of Biological Chemistry|2007Cited by 62
Identification and Preliminary Characterization of a Potent, Safe, and Orally Efficacious Inhibitor of Acyl-CoA:Diacylglycerol Acyltransferase 1Vince S. C. Yeh, Andrew J. Souers, David W. A. Beno et al.|Journal of Medicinal Chemistry|2012Cited by 34